Compare Smith & Nephew plc (SNN) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Twist Bioscience Corp — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Smith & Nephew plc is far larger — about 2.3× Twist Bioscience Corp's market cap, and Smith & Nephew plc pays a 2.57% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| SNN | TWST | |
|---|---|---|
Market Cap | $12.64B | $5.45B |
Sector | Health | Health |
52-Week High | $38.70 | $102.88 |
52-Week Low | $28.73 | $24.16 |
Enterprise Value | $15.41B | $5.37B |
Dividend Yield | 2.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
